Recruiting studies: Icans

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Temporal Characterization of Extracellular Vesicles During Cellular Therapy Using CAR-T Cells and During the Occurrence
Phase 4 · 1 location(s) · Centre Hospitalier Universitaire de Saint Etienne · NCT06706102 Neuroimaging and Biomarkers of Neurotoxicity After Chimeric Antigen Receptor T-Cell Therapy
Phase N/A · 1 location(s) · University of California, San Diego · NCT07075523 A Phase II Study of Siltuximab for CRS/ICANs After CAR-T in Multiple Myeloma
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT07106671 Adjunctive Methylene Blue for Immunotherapy-related CRS and ICANS: Phase I Study
Phase 1 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT07169487 PRONTO Trial (PRophylactic Versus ON-demand Use of TOcilizumab)
Phase 2 · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT06430736 NexCAR19 (Talikabtagene Autoleucel) in Relapsed/Refractory B-Cell Malignancies (NexCAR19)
Phase 2/Phase 3 · 4 location(s) · Health Institutes of Turkey · NCT07502118 Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
Phase 2 · 17 location(s) · SCRI Development Innovations, LLC · NCT05972135

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.